The Parker Institute for Cancer Immunotherapy awards over $1M to five early-stage career cancer researchers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Parker Institute for Cancer Immunotherapy, a collaborative consortium of immuno-oncology experts that bridges scientific discovery and commercialization of cancer therapies, announced its 2025 class of Early Career Researcher awardees. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login